Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

NCT03489408 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-02-20

No results posted yet for this study

Summary

The purpose of this study is to collect device and procedure experience in everyday clinical practice. The patients are being asked to participate in this study because they are a surgical candidate for the treatment of a broken shoulder and are considering treatment with the PH Cage device.

Conditions

  • Humeral Fractures, Proximal

Interventions

DEVICE

Conventus Cage™ PH

Proximal humeral fracture fixation

Sponsors & Collaborators

  • Conventus Orthopaedics, Inc.

    lead INDUSTRY

Principal Investigators

  • Carrie Hill · Conventus Orthopaedics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2020-02-17
Completion
2020-02-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03489408 on ClinicalTrials.gov